Merck KGaA, Darmstadt, Germany
Merck KGaA, Darmstadt, Germany

Clinical Trial Information

Clinical Trial Information
A commitment to the highest ethical standards
Merck KGaA, Darmstadt, Germany, its prescription medicines division and its worldwide affiliates are dedicated to developing innovative medicines that address unmet medical needs. We carry out clinical trials to evaluate, for each investigational drug and marketed product, whether it is safe and effective.

Our clinical trials follow the highest medical and ethical standards, in accordance with the principles laid down in the Declaration of Helsinki, and that are consistent with Good Clinical Practice and applicable regulations.

By making such clinical trial information available, we are:

  • Informing patients, investigators and healthcare professionals about the clinical research it conducts.
  • Promoting the distribution of knowledge and minimize the duplication of research effort.
  • Supporting the publication of full manuscripts in peer-reviewed journals.
  • Contributing towards transparency and build mutual trust.

With respect to the principles set forth by the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), the Declaration of Helsinki and applicable regulations, we are informing the public about the designs and results of our clinical trials in a timely and balanced manner, regardless of the outcome. We are committed to register clinical trials, which are sponsored by our company, on the U.S National Institutes of Health´s website.  In addition, we are posting the designs and findings from clinical trials which are sponsored by us, on further national trial registers as mandated by local requirements.

Merck KGaA, Darmstadt, Germany, its prescription medicines division and its worldwide affiliates are not to be considered sponsors of Investigator Sponsored Trials or trials funded by Independent Medical Grants. The responsibility for registering these trial designs and results resides with the sponsor of the trial.


Publication of Merck KGaA, Darmstadt, Germany.
There are two different, unaffiliated companies that use the name MERCK. Merck KGaA, Darmstadt, Germany, which operates this website, uses the firm name “Merck KGaA, Darmstadt, Germany,” in the United States and Canada, and also uses “EMD Serono” in biopharma, “MilliporeSigma” in life science and “EMD Performance Materials” in materials business. The other company, Merck & Co., Inc. holds the rights in the trademark MERCK in the United States and Canada. Merck & Co. is not affiliated with or related to Merck KGaA, Darmstadt, Germany, which owns the MERCK trademark in all other countries of the world.   To reflect such fact and to avoid any confusion, certain logos, terms and business descriptions of the publications on this website have been substituted or modified, such as by referring to “Merck KGaA, Darmstadt, Germany” instead of “Merck” standing alone.  Publications on this webpage, therefore, slightly deviate from the otherwise identical versions accessible outside the United States and Canada.